The coronavirus has been affecting our everyday life for the last months, a major challenge for all of us. R-Biopharm continuously faces its social responsibility to meet the diagnostic requirements for the detection of SARS-CoV-2.

With more than 30 years’ experience in clinical diagnostics, we already support the healthcare sector in containment and control of the coronavirus pandemic with our SARS-CoV-2 PCR assay since February 2020. R-Biopharm constantly adapts and expands its portfolio to the new requirements of the COVID-19 pandemic.

Coronavirus

Immunochromatographic rapid test for the qualitative detection of SARS-CoV-2 specific antigens.

Coronavirus

Multiplex real-time RT-PCR for the direct qualitative detection of the coronavirus (SARS-CoV-2) RNA.

Coronavirus

Multiplex real-time RT-PCR for the direct qualitative detection and differentiation of the influenza A/B and coronavirus (SARS-CoV-2) RNA.

RIDA®QUICK SARS-CoV-2 antigen rapid test

  • Official partner of the German Federal Ministry of Health for SARS-CoV-2 diagnostics to fight COVID-19
  • Easy test procedure including a swab sampling collection device
  • Swab system with duplex- transport media allows for PCR-confirmation testing from the same sample applicable for nasal and / or throat swabs
  • BfArM (Federal Institute for Drugs and Medical Devices) listed antigen test for the direct detection of the coronavirus SARS-CoV-2
  • According to Paul-Ehrlich-Institute, the analytical sensitivity corresponds to the state of the art
  • Sensitivity of 95 % with a PCR-Ct value of < 29, as well as a specificity of 100 % (study by the Charité, Prof. Dr. Drosten and Frankfurt University Hospital, Prof. Dr. Ciesek)
Coronavirus
Coronavirus

RIDA®GENE SARS-CoV-2 real-time PCR test

  • Qualitative specific detection of SARS-CoV-2 (E gene) from respiratory sample material
  • The assay can be run on commonly used real-time PCR instruments
  • Results in less than 1.5 h
  • FindDx (Foundation for Innovative New Diagnostics) listed PCR test
  • Suitable for laboratories with high throughput for the initial diagnosis and as confirmatory test after a positive rapid test result
  • Meets the WHO recommendation for areas where COVID-19 virus is widely spread
  • All controls (internal, positive, negative) are included in the kit

RIDA®GENE Flu & SARS-CoV-2 multiplex test

  • Qualitative detection and differentiation of Influenza A/B (M gene/NP1 gene) and SARS-CoV-2 (E gene; RdRp gene) respiratory sample material
  • The assay can be run on commonly used real-time PCR instruments
  • Results in less than 1.5 h
  • Detection of two SARS-CoV-2 specific gene fragments within the E gene and RdRp gene
  • All controls (internal, positive, negative) are included in the kit
Coronavirus

Start typing and press Enter to search